Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal.
about
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@en
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@nl
type
label
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@en
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@nl
prefLabel
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@en
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@nl
P2093
P2860
P1476
Population pharmacokinetic ana ...... m the RE-LY trial: a rebuttal.
@en
P2093
P2860
P304
500-2; author reply 502-4
P356
10.1111/J.1538-7836.2011.04579.X
P50
P577
2012-03-01T00:00:00Z